Literature DB >> 29535426

Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia.

Sarah D Cramer1,2, Julie A Hixon1, Caroline Andrews1, Ross J Porter1,3, Gisele O L Rodrigues1,4,5, Xiaolin Wu6, Tim Back1, Kelli Czarra1, Helen Michael7, Maggie Cam8, Jack Chen8, Dominic Esposito9, Emilee Senkevitch1, Vijay Negi10, Peter D Aplan10, Wenqing Li1, Scott K Durum11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29535426      PMCID： PMC7984718          DOI： 10.1038/s41375-017-0001-0

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

Authors:  Yifang Hu; Gordon K Smyth
Journal:  J Immunol Methods       Date:  2009-06-28       Impact factor: 2.303

Review 2.  Targeting oncogenic Ras signaling in hematologic malignancies.

Authors:  Ashley F Ward; Benjamin S Braun; Kevin M Shannon
Journal:  Blood       Date:  2012-08-16       Impact factor: 22.113

Review 3.  How new advances in genetic analysis are influencing the understanding and treatment of childhood acute leukemia.

Authors:  Kathryn G Roberts; Charles G Mullighan
Journal:  Curr Opin Pediatr       Date:  2011-02       Impact factor: 2.856

4.  Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.

Authors:  Priscila P Zenatti; Daniel Ribeiro; Wenqing Li; Linda Zuurbier; Milene C Silva; Maddalena Paganin; Julia Tritapoe; Julie A Hixon; André B Silveira; Bruno A Cardoso; Leonor M Sarmento; Nádia Correia; Maria L Toribio; Jörg Kobarg; Martin Horstmann; Rob Pieters; Silvia R Brandalise; Adolfo A Ferrando; Jules P Meijerink; Scott K Durum; J Andrés Yunes; João T Barata
Journal:  Nat Genet       Date:  2011-09-04       Impact factor: 38.330

5.  NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia.

Authors:  Ying-Wei Lin; Christopher Slape; Zhenhua Zhang; Peter D Aplan
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

6.  Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.

Authors:  K Nguyen; M Devidas; S-C Cheng; M La; E A Raetz; W L Carroll; N J Winick; S P Hunger; P S Gaynon; M L Loh
Journal:  Leukemia       Date:  2008-09-25       Impact factor: 11.528

Review 7.  Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment.

Authors:  Sarah D Cramer; Peter D Aplan; Scott K Durum
Journal:  Blood       Date:  2016-06-06       Impact factor: 22.113

8.  Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential.

Authors:  Louise M Treanor; Sheng Zhou; Laura Janke; Michelle L Churchman; Zhijun Ma; Taihe Lu; Shann-Ching Chen; Charles G Mullighan; Brian P Sorrentino
Journal:  J Exp Med       Date:  2014-03-31       Impact factor: 14.307

9.  MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia.

Authors:  K Canté-Barrett; J A P Spijkers-Hagelstein; J G C A M Buijs-Gladdines; J C M Uitdehaag; W K Smits; J van der Zwet; R C Buijsman; G J R Zaman; R Pieters; J P P Meijerink
Journal:  Leukemia       Date:  2016-04-22       Impact factor: 11.528

10.  TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes.

Authors:  Min Zhao; Pora Kim; Ramkrishna Mitra; Junfei Zhao; Zhongming Zhao
Journal:  Nucleic Acids Res       Date:  2015-11-20       Impact factor: 16.971
View more
  10 in total

1.  Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia.

Authors:  David M Langenau; João T Barata; Mariana L Oliveira; Alexandra Veloso; Elaine G Garcia; Sowmya Iyer; Clara Pereira; Vasco M Barreto
Journal:  Leukemia       Date:  2022-05-17       Impact factor: 12.883

2.  New anti-IL-7Rα monoclonal antibodies show efficacy against T cell acute lymphoblastic leukemia in pre-clinical models.

Authors:  Julie A Hixon; Caroline Andrews; Lila Kashi; Casey L Kohnhorst; Emilee Senkevitch; Kelli Czarra; Joao T Barata; Wenqing Li; Joel P Schneider; Scott T R Walsh; Scott K Durum
Journal:  Leukemia       Date:  2019-08-22       Impact factor: 11.528

Review 3.  Flip the coin: IL-7 and IL-7R in health and disease.

Authors:  João T Barata; Scott K Durum; Benedict Seddon
Journal:  Nat Immunol       Date:  2019-11-19       Impact factor: 25.606

4.  Interleukin (IL)-7 Signaling in the Tumor Microenvironment.

Authors:  Iwona Bednarz-Misa; Mariusz A Bromke; Małgorzata Krzystek-Korpacka
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update.

Authors:  Camilla Evangelisti; Francesca Chiarini; James A McCubrey; Alberto M Martelli
Journal:  Int J Mol Sci       Date:  2018-06-26       Impact factor: 5.923

6.  Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia.

Authors:  J Andrés Yunes; João T Barata; Afonso R M Almeida; João L Neto; Ana Cachucho; Mayara Euzébio; Xiangyu Meng; Rathana Kim; Marta B Fernandes; Beatriz Raposo; Mariana L Oliveira; Daniel Ribeiro; Rita Fragoso; Priscila P Zenatti; Tiago Soares; Mafalda R de Matos; Juliana Ronchi Corrêa; Mafalda Duque; Kathryn G Roberts; Zhaohui Gu; Chunxu Qu; Clara Pereira; Susan Pyne; Nigel J Pyne; Vasco M Barreto; Isabelle Bernard-Pierrot; Emannuelle Clappier; Charles G Mullighan; Ana R Grosso
Journal:  Nat Commun       Date:  2021-12-14       Impact factor: 14.919

Review 7.  The Role of IL-7 and IL-7R in Cancer Pathophysiology and Immunotherapy.

Authors:  Chunli Wang; Lingzu Kong; Seokmin Kim; Sunyoung Lee; Sechan Oh; Seona Jo; Inhwan Jang; Tae-Don Kim
Journal:  Int J Mol Sci       Date:  2022-09-08       Impact factor: 6.208

8.  Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice.

Authors:  Kerri R Thomas; Eric J Allenspach; Nathan D Camp; Michelle N Wray-Dutra; Socheath Khim; Anna Zielinska-Kwiatkowska; Andrew E Timms; Joseph P Loftus; H Denny Liggitt; Katia Georgopoulos; Sarah K Tasian; Richard G James; David J Rawlings
Journal:  Leukemia       Date:  2021-06-30       Impact factor: 11.528

Review 9.  The effect of co-occurring lesions on leukaemogenesis and drug response in T-ALL and ETP-ALL.

Authors:  Paniz Tavakoli Shirazi; Laura N Eadie; Susan L Heatley; Timothy P Hughes; David T Yeung; Deborah L White
Journal:  Br J Cancer       Date:  2019-12-03       Impact factor: 7.640

10.  An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia.

Authors:  Ifat Geron; Angela Maria Savino; Hila Fishman; Noa Tal; John Brown; Virginia A Turati; Chela James; Jolanda Sarno; Michal Hameiri-Grossman; Yu Nee Lee; Avigail Rein; Hillary Maniriho; Yehudit Birger; Anna Zemlyansky; Inna Muler; Kara L Davis; Victoria Marcu-Malina; Nicole Mattson; Oren Parnas; Rabea Wagener; Ute Fischer; João T Barata; Catriona H M Jamieson; Markus Müschen; Chun-Wei Chen; Arndt Borkhardt; Ilan Richard Kirsch; Arnon Nagler; Tariq Enver; Shai Izraeli
Journal:  Nat Commun       Date:  2022-02-03       Impact factor: 17.694
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.